Optimization of pH-independent chronotherapeutic release of verapamil HCl from three-layer matrix tablets

• Published in: International journal of pharmaceutics 2015-10, Vol.494 (1), p.296-303
• Main Authors: Al-Zoubi, Nizar, Alkhatib, Hatim S., Alobaidi, Ghadah, Abdel-Rahim, Safwan, Obeidat, Wasfy, Malamataris, Stavros
• Format: Article
• Language: English
• Subjects: Alginates - chemistry; Artificial neural networks; Chemistry, Pharmaceutical; Chronodelivery; Delayed-Action Preparations - chemistry; Drug Chronotherapy; Drug Liberation; Glucuronic Acid - chemistry; Hexuronic Acids - chemistry; Hydrogen-Ion Concentration; Models, Statistical; Neural Networks (Computer); Polysaccharides, Bacterial - chemistry; Sodium alginate; Tablets - chemistry; Three-layer matrix tablets; Verapamil - chemistry; Xanthan gum
• ISSN: 0378-5173; 1873-3476
• DOI: 10.1016/j.ijpharm.2015.08.021

The aim of this work was to evaluate and optimize formulation of three-layer matrix tablets based on xanthan gum (XG) and sodium alginate for chronotherapeutic pH-independent release of verapamil HCl (VH). Artificial neural networks (ANN) were applied in the optimization and compared with multiple linear regression (MLR). A face-centered central composite experimental design was employed with three factors (mass fraction of VH in intermediate layer, X1, and of XG in matrix former of intermediate and outer layers, X2 and X3). The prepared tablets were tested for in vitro release in 0.1N HCl and phosphate buffer (pH 7.5), tensile strength and friability. Furthermore, swelling observation and release modeling to Weibull function and power law equation of Peppas were employed to help further understanding of release behavior and mechanism. The releases (%) in phosphate buffer (pH 7.5) at 6, 12 and 24h were selected as responses to depict the mode of release and similarity factor (f2), between release profiles in 0.1N HCl and pH 7.5 during the first 8h, as response of pH-independence. A desirability function combining the four responses was constructed and overall desirability values were used for the ANN and MLR modeling. Five additional checkpoint formulations, within the experimental domain, were used to validate the external predictability of the models. The constructed ANN model fitted better to the overall desirability than the MLR model (R=0.838 vs. 0.670, for the additional checkpoint formulations) and therefore, was used for prediction of formulation with optimal in vitro drug release.